UMBF vs. ZYME
UMBF (UMB Financial Corporation) and ZYME (Zymeworks Inc.) are both stocks. UMBF operates in Banks - Regional (Financial Services), while ZYME operates in Biotechnology (Healthcare). Over the past 5 years, UMBF returned 10.03%/yr vs -8.24%/yr for ZYME. At a 0.17 correlation, their price movements are largely independent.
Performance
UMBF vs. ZYME - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UMBF achieves a 22.10% return, which is significantly higher than ZYME's -9.30% return.
UMBF
- 1D
- 1.85%
- 1M
- 6.65%
- YTD
- 22.10%
- 6M
- 17.83%
- 1Y
- 39.10%
- 3Y*
- 36.69%
- 5Y*
- 10.03%
- 10Y*
- 12.04%
ZYME
- 1D
- 2.67%
- 1M
- -6.76%
- YTD
- -9.30%
- 6M
- -10.86%
- 1Y
- 91.50%
- 3Y*
- 43.33%
- 5Y*
- -8.24%
- 10Y*
- —
UMBF vs. ZYME - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
UMBF UMB Financial Corporation | 22.10% | 3.44% | 37.34% | 2.21% | -19.97% | 56.04% | 2.64% | 14.71% | -13.86% | -3.17% |
ZYME Zymeworks Inc. | -9.30% | 79.85% | 40.90% | 32.19% | -52.04% | -65.32% | 3.96% | 209.67% | 93.33% | -43.75% |
Correlation
The correlation between UMBF and ZYME is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Apr 28, 2017 | 0.17 |
Fundamentals
UMBF:
$15.48
ZYME:
-$583.41
UMBF:
1.78
ZYME:
22.95
UMBF:
$4.46B
ZYME:
$78.86M
UMBF:
$1.99B
ZYME:
$77.16M
UMBF:
$937.72M
ZYME:
-$47.18B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UMBF vs. ZYME — Risk / Return Rank
UMBF
ZYME
UMBF vs. ZYME - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for UMB Financial Corporation (UMBF) and Zymeworks Inc. (ZYME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UMBF | ZYME | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.28 | ||
| Sortino ratioReturn per unit of downside risk | -0.70 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.33 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 2.11 | 4.33 | -2.21 |
| Martin ratioReturn relative to average drawdown | 4.89 | 9.21 | -4.32 |
Loading charts...
Drawdowns
UMBF vs. ZYME - Drawdown Comparison
The maximum UMBF drawdown since its inception was -52.70%, smaller than the maximum ZYME drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for UMBF and ZYME.
Loading charts...
Drawdown Indicators
| UMBF | ZYME | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -52.70% | -91.81% | +39.11% |
Max Drawdown (1Y)Largest decline over 1 year | -18.57% | -21.25% | +2.68% |
Max Drawdown (3Y)Largest decline over 3 years | -31.80% | -45.75% | +13.95% |
Max Drawdown (5Y)Largest decline over 5 years | -50.25% | -87.53% | +37.28% |
Max Drawdown (10Y)Largest decline over 10 years | -50.25% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -57.97% | +57.97% |
Average DrawdownAverage peak-to-trough decline | -17.75% | -52.54% | +34.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.02% | 9.97% | -1.95% |
Volatility
UMBF vs. ZYME - Volatility Comparison
The current volatility for UMB Financial Corporation (UMBF) is 7.27%, while Zymeworks Inc. (ZYME) has a volatility of 10.12%. This indicates that UMBF experiences smaller price fluctuations and is considered to be less risky than ZYME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UMBF | ZYME | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.27% | 10.12% | -2.85% |
Volatility (6M)Calculated over the trailing 6-month period | 18.46% | 29.45% | -10.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.01% | 52.91% | -25.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.22% | 61.85% | -28.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.47% | 61.45% | -27.98% |
Dividends
UMBF vs. ZYME - Dividend Comparison
UMBF's dividend yield for the trailing twelve months is around 1.21%, while ZYME has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
UMBF UMB Financial Corporation | 1.21% | 1.42% | 1.39% | 1.83% | 1.78% | 1.30% | 1.81% | 1.76% | 1.92% | 1.45% | 1.28% | 2.04% |
ZYME Zymeworks Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
UMBF vs. ZYME - Financials Comparison
This section allows you to compare key financial metrics between UMB Financial Corporation and Zymeworks Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
UMBF and ZYME have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZYME has higher volatility (10.12%) compared to UMBF (7.27%). In terms of maximum drawdown, UMBF dropped -52.70% vs ZYME's -91.81%.
ZYME currently has the higher Sharpe Ratio (1.74 vs 1.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UMBF and ZYME
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer